Citadel Advisors - INNATE PHARMA S A ownership

INNATE PHARMA S A's ticker is IPHA and the CUSIP is 45781K204. A total of 9 filers reported holding INNATE PHARMA S A in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of INNATE PHARMA S A
ValueSharesWeighting
Q2 2023$41,702
-61.7%
13,281
-47.4%
0.00%
Q1 2021$109,00025,2500.00%
Other shareholders
INNATE PHARMA S A shareholders Q3 2023
NameSharesValueWeighting ↓
Optiver Holding B.V. 181,944$491,0000.00%
BANK OF AMERICA CORP /DE/ 175,229$473,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 16,856$46,0000.00%
CREDIT SUISSE AG/ 1,981$5,0000.00%
CITIGROUP INC 55$00.00%
MORGAN STANLEY 46,598$126,0000.00%
BlackRock Inc. 497,275$1,343,0000.00%
CAPTRUST FINANCIAL ADVISORS 905$2,0000.00%
Steward Partners Investment Advisory, LLC 500$1,0000.00%
View complete list of INNATE PHARMA S A shareholders